Abstract: The present disclosure includes systems, devices, and methods for preventing contamination during formation of an optical article. In some implementations, a device for preventing contamination of a mold cavity during injection molding of a function wafer includes a containment band having an annular base that defines a first opening configured to receive a functional wafer. The device also includes one or more sidewalls that project a first direction from and surround at least a portion of the first opening. The one or more sidewalls may be configured such that, during formation of an optical article, a first portion of the functional wafer is in contact with the one or more sidewalls.

Abstract: The present disclosure includes systems, devices, and methods for preventing contamination during formation of an optical article. In some implementations, a device for preventing contamination of a mold cavity during injection molding of a function wafer includes a containment band having an annular base that defines a first opening configured to receive a functional wafer. The device also includes one or more sidewalls that project a first direction from and surround at least a portion of the first opening. The one or more sidewalls may be configured such that, during formation of an optical article, a first portion of the functional wafer is in contact with the one or more sidewalls.

Abstract: Disclosed is a method for determining at least one geometrico-morphological parameter of a subject for determining a vision correction equipment, wherein the following steps are performed: a) determining the height of one of the eyes of the subject (P) relative to a reference horizontal surface; b) placing a visual target in front of the head (HP) of the subject (P) at a predetermined position, this predetermined position being determined taking into account the height of one of the eyes of the subject relative to the reference horizontal surface, determined in step a); c) while the subject gazes at the visual target placed at the predetermined position in step b), capturing an image of the head (HP) of the subject (P) with an image capture apparatus (50); and d) deducing from the image captured in step c) the at least one geometrico-morphological parameter.

Abstract: The invention provides a system for coating an optical article with a coating composition (50), comprising a chamber configured to receive said article, a coating device configured to carry out a coating treatment of said composition for depositing it on said article in said chamber, by vaporizing said composition and by exposing at least a face of said article to the vaporized composition, and a control unit configured to control said coating device for coating said article by vaporizing said composition; said coating device being formed as a single cartridge unit comprising a casing (41) configured to contain said composition, a vaporizing conduit (49) opening both into said casing and outside of said coating device, and a propelling member (52) configured to pressurize said composition; said coating device being configured to put in fluidic communication said propelling member in an operative state with said casing in order to carry out said coating treatment for coating an article.

Abstract: The present disclosure includes systems, devices, and methods for preventing contamination during formation of an optical article. In some implementations, a device for preventing contamination of a mold cavity during injection molding of a function wafer includes a containment band having an annular base that defines a first opening configured to receive a functional wafer. The device also includes one or more sidewalls that project a first direction from and surround at least a portion of the first opening. The one or more sidewalls may be configured such that, during formation of an optical article, a first portion of the functional wafer is in contact with the one or more sidewalls.

Abstract: The invention concerns a method for obtaining and selecting monoclonal antibodies by an ADDC-type test, said antibodies capable of activating type III Fcy receptors and having a particular glycan structure. The inventive anti-D antibodies can be used for preventing Rhesus isoimmunization in Rh negative persons, in particular for hemolytic disease in a new-born baby of for uses such as idiopathic thrombocytopenic pupura 9ITP).

Abstract: The invention provides a system for coating an optical article with a coating composition (50), comprising a chamber configured to receive said article, a coating device configured to carry out a coating treatment of said composition for depositing it on said article in said chamber, by vaporizing said composition and by exposing at least a face of said article to the vaporized composition, and a control unit configured to control said coating device for coating said article by vaporizing said composition; said coating device being formed as a single cartridge unit comprising a casing (41) configured to contain said composition, a vaporizing conduit (49) opening both into said casing and outside of said coating device, and a propelling member (52) configured to pressurize said composition; said coating device being configured to put in fluidic communication said propelling member in an operative state with said casing in order to carry out said coating treatment for coating an article.

Abstract: The invention concerns a method for obtaining and selecting monoclonal antibodies by an ADDC-type test, said antibodies capable of activating type III Fcy receptors and having a particular glycan structure.

Abstract: The invention concerns a method for obtaining and selecting monoclonal antibodies by an ADCC-type test, said antibodies capable of activating type III Fcy receptors and having a particular glycan structure. The inventive anti-D antibodies can be used for preventing Rhesus isoimmunization in Rh negative persons, in particular for hemolytic disease in a new-born baby or for uses such as idiopathic thrombocytopenic purpura (ITP).

Abstract: The invention concerns a method for obtaining and selecting monoclonal antibodies by an ADDC-type test, said antibodies capable of activating type III Fcy receptors and having a particular glycan structure. The inventive anti-D antibodies can be used for preventing Rhesus isoimmunisation in Rh negative persons, in particular for haemolytic disease in a new-born baby of for uses such as idiopathic thrombocytopenic pupura 9ITP).

Abstract: A bi-layer adhesive and a method for laminating a film onto an optical article utilizing the bi-layer adhesive are described. A method for laminating the film onto an optical article and the bi-layer adhesive for use in the method are also described. The bi-layer adhesive includes a latex adhesive layer and an HMA layer sequentially disposed on the film and dried to form a solid layer of uniform thinness throughout to provide optical quality. Various types of films may be employed to provide an optical function. Following optional pre-treatment steps, the bi-layer adhesive is coated on to the film. An optical hot press technique is used to deliver heat and pressure over a short period of time to form a functionally-enhanced optical article with high adhesive strength.

Abstract: The invention concerns a method for obtaining and selecting monoclonal antibodies by an ADDC-type test, said antibodies capable of activating type III Fcy receptors and having a particular glycan structure.

Abstract: A method for laminating a film on to an optical article and a bi-layer adhesive for use in the method. The bi-layer adhesive includes a latex adhesive layer and an HMA layer sequentially disposed on the film and dried to form a solid layer of uniform thinness throughout to provide optical quality. Various types of films may be employed to provide an optical function. Following optional pre-treatment steps, the adhesives are coated on to the film. An optical hot press technique is used to deliver heat and pressure over a short period of time to form a functionally-enhanced optical article with high adhesive strength.

Abstract: The invention concerns a method for obtaining and selecting monoclonal antibodies by an ADDC-type test, said antibodies capable of activating type III Fcy receptors and having a particular glycan structure.

Abstract: The invention concerns a method for obtaining and selecting monoclonal antibodies by an ADDC-type test, said antibodies capable of activating type III Fcy receptors and having a particular glycan structure. The inventive anti-D antibodies can be used for preventing Rhesus isoimmunization in Rh negative persons, in particular for haemolytic disease in a new-born baby of for uses such as idiopathic thrombocytopenic pupura 9ITP.

Abstract: The invention concerns a method for obtaining and selecting monoclonal antibodies by an ADDC-type test, said antibodies capable of activating type III Fcy receptors and having a particular glycan structure. The inventive anti-D antibodies can be used for preventing Rhesus isoimmunization in Rh negative persons, in particular for haemolytic disease in a new-born baby of for uses such as idiopathic thrombocytopenic purpura (ITP).

Abstract: A method of dip-coating a lens includes the steps of: immersing the lens (10) in a coating solution bath (2) having a horizontal coating solution surface (4), and withdrawing the lens (10) from the bath (2) through the solution surface (4). The step of withdrawing is performed with a movement of the lens such that the orientation of the lens (10) varies continuously, from a position in which the optical axis (A) of the lens (10) is inclined upwards and towards the concave surface (12) of the lens (10) when the lens (10) starts emerging from the bath (2) to a position in which the optical axis (A) of the lens (10) is inclined upwards and towards the convex surface (11) of the lens (10) when the lens (10) finishes emerging from the bath (2).

Abstract: The invention concerns a method for obtaining and selecting monoclonal antibodies by an ADDC-type test, said antibodies capable of activating type III Fc? receptors and having a particular glycan structure. The inventive anti-D antibodies can be used for preventing Rhesus isoimmunisation in Rh negative persons, in particular for haemolytic disease in a new-born baby or for uses such as idiopathic thrombocytopenic purpura (ITP).

Abstract: The invention concerns a method for obtaining and selecting monoclonal antibodies by an ADDC-type test, said antibodies capable of activating type III Fcy receptors and having a particular glycan structure.

Abstract: The invention concerns a method for obtaining and selecting monoclonal antibodies by an ADDC-type test, said antibodies capable of activating type III Fc? receptors and having a particular glycan structure. The inventive anti-D antibodies can be used for preventing Rhesus isoimmunisation in Rh negative persons, in particular for haemolytic disease in a new-born baby or for uses such as idiopathic thrombocytopenic purpura (ITP).